Hasil Pencarian - Johan Dobber
- Menampilkan 1 - 3 hasil dari 3
-
1
P634: EARLY-STAGE MEASURABLE RESIDUAL DISEASE DYNAMICS AND IGHV REPERTOIRE RECONSTITUTION DURING VENETOCLAX AND OBINUTUZUMAB TREATMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA oleh Paul Hengeveld, Joyce Schilperoord-Vermeulen, Michèle van der Klift, Julie Dubois, Pieter Martijn Kolijn, François Kavelaars, Melissa Rijken, Johan Dobber, Kazem Nasserinejad, Sabina Kersting, Peter Westerweel, Arnon Kater, Anton Langerak, Mark-David Levin
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
2
S148: TIME-LIMITED VENETOCLAX AND IBRUTINIB FOR PATIENTS WITH RELAPSED/REFRACTORY CLL WHO HAVE UNDETECTABLE MRD – 4-YEAR FOLLOW UP FROM THE RANDOMIZED PHASE II VISION/HO141 TRIAL oleh Arnon Kater, Julie Dubois, Christian Brieghel, Sabina Kersting, Lisbeth Enggaard, Gerrit Veldhuis, Rogier Mous, Clemens Mellink, Johan Dobber, Christian Poulsen, Caspar Da Cunha-Bang, Hendrik Fredriksen, Ann Janssens, Ida Schjodt, Ellen Dompeling, Juha Ranti, Mattias Mattsson, Mar Bellido, Hoa Tran, Kazem Nasserinejad, Mark-David Levin, Carsten Niemann
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
3
P619: TRACKING DISEASE PARAMETERS BY MRD, CT AND PET IN FIRST LINE CLL PATIENTS TREATED WITH FIXED DURATION IBRUTINIB-VENETOCLAX; INTERIM ANALYSIS OF THE FIRST 30 PATIENTS IN HOVON... oleh Sabina Kersting, Mark-David Levin, Julie Dubois, Yvette van Norden, Johan Dobber, Yvonne Jauw, Anne-Marie van der Kevie-Kersemaekers, Clemens Mellink, Caspar Da Cunha-Bang, Leonie Van Desr Burg, Doreen Te Raa, Fransien de Boer, Jolanda Droogendijk, Cecile Idink, Koen De Heer, Marten Nijziel, Lidwine Tick, Inge Ludwig, Mathijs Silbermann, Aart Beeker, Mar Bellido, Ludo Evers, Gerben Zwezerijnen, Josée Zijlstra, Marcel Kap, Carsten Niemann, Arnon Kater
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel